Trials / Completed
CompletedNCT04526054
Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients
Longitudinal and Comparative Study of Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Hopital Foch · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Olfactory and gustatory disorders are prevalent symptoms in European COVID-19 patients. This study aimed to detect these disturbances among positive COVID-19 patients (symptom not initially highlighted by the patient and not sought by caregivers) in order to allow early management of olfactory and gustatory dysfunction.
Detailed description
Several medical teams have recently shown that disturbances of smell and taste are common and can be a precursor and even an isolated sign of COVID-19 involvement. Preliminary results suggest the presence of clinical MRI abnormalities, particularly in the olfactory bulbs in anosmic patients with COVID-19. Anosmia and taste disturbance are early warning signs that could be important in improving the detection and diagnosis of COVID-19, and also in monitoring disease. In addition, disturbances in smell and taste could be an aid in establishing the prognosis of the clinical course of the viral disease. The question of olfactory recovery is also fundamental. To date, we do not know the possibilities of recovery from COVID-19 post viral anosmia. ENT exams, olfactometry and MRI are proposed to study these phenomena.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | ENT exam | ENT examination of the nasal cavity: nasofibroscopy and anterior rhinoscopy. |
| DIAGNOSTIC_TEST | Olfactometry | Olfactometry test using odorous pens (Sniffin's stick test). |
| DIAGNOSTIC_TEST | Brain MRI | Brain MRI focused on the olfactory bulbs (3 teslas). |
Timeline
- Start date
- 2020-09-03
- Primary completion
- 2021-09-03
- Completion
- 2021-09-03
- First posted
- 2020-08-25
- Last updated
- 2022-08-03
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04526054. Inclusion in this directory is not an endorsement.